- Home
- RAPT vs CTW Comparison
RAPT vs CTW Comparison
Compare RAPT & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CTW
- Stock Information
- Founded
- RAPT 2015
- CTW 2013
- Country
- RAPT United States
- CTW Japan
- Employees
- RAPT N/A
- CTW N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CTW EDP Services
- Sector
- RAPT Health Care
- CTW Technology
- Exchange
- RAPT Nasdaq
- CTW Nasdaq
- Market Cap
- RAPT 194.2M
- CTW 171.4M
- IPO Year
- RAPT 2019
- CTW 2025
- Fundamental
- Price
- RAPT $13.18
- CTW $1.96
- Analyst Decision
- RAPT Buy
- CTW
- Analyst Count
- RAPT 5
- CTW 0
- Target Price
- RAPT $33.60
- CTW N/A
- AVG Volume (30 Days)
- RAPT 117.5K
- CTW 182.7K
- Earning Date
- RAPT 08-07-2025
- CTW 01-01-0001
- Dividend Yield
- RAPT N/A
- CTW N/A
- EPS Growth
- RAPT N/A
- CTW N/A
- EPS
- RAPT N/A
- CTW N/A
- Revenue
- RAPT N/A
- CTW $76,194,020.00
- Revenue This Year
- RAPT N/A
- CTW N/A
- Revenue Next Year
- RAPT N/A
- CTW N/A
- P/E Ratio
- RAPT N/A
- CTW $46.47
- Revenue Growth
- RAPT N/A
- CTW 8.71
- 52 Week Low
- RAPT $5.67
- CTW $1.71
- 52 Week High
- RAPT $26.56
- CTW $4.88
- Technical
- Relative Strength Index (RSI)
- RAPT 63.64
- CTW N/A
- Support Level
- RAPT $11.19
- CTW N/A
- Resistance Level
- RAPT $13.66
- CTW N/A
- Average True Range (ATR)
- RAPT 0.75
- CTW 0.00
- MACD
- RAPT 0.19
- CTW 0.00
- Stochastic Oscillator
- RAPT 86.53
- CTW 0.00
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.